Background And Objective: Very preterm infants are susceptible to neurodevelopmental impairments, necessitating early detection of prognostic biomarkers for timely intervention. The study aims to explore possible functional biomarkers for very preterm infants at born that relate to their future cognitive and motor development using resting-state fMRI. Prior studies are limited by the sample size and suffer from efficient functional connectome (FC) construction algorithms that can handle the noisy data contained in neonatal time series, leading to equivocal findings. Therefore, we first propose an enhanced functional connectome construction algorithm as a prerequisite step. We then apply the new FC construction algorithm to our large prospective very preterm cohort to explore multi-level neurodevelopmental biomarkers.
Methods: There exists an intrinsic relationship between the structural connectome (SC) and FC, with a notable coupling between the two. This observation implies a putative property of graph signal smoothness on the SC as well. Yet, this property has not been fully exploited for constructing intrinsic dFC. In this study, we proposed an advanced dynamic FC (dFC) learning model, dFC-Igloo, which leveraged SC information to iteratively refine dFC estimations by applying graph signal smoothness to both FC and SC. The model was evaluated on artificial small-world graphs and simulated graph signals.
Results: The proposed model achieved the best and most robust recovery of the ground truth graph across different noise levels and simulated SC pairs from the simulation. The model was further applied to a cohort of very preterm infants from five Neonatal Intensive Care Units, where an enhanced dFC was obtained for each infant. Based on the improved dFC, we identified neurodevelopmental biomarkers for neonates across connectome-wide, regional, and subnetwork scales.
Conclusion: The identified markers correlate with cognitive and motor developmental outcomes, offering insights into early brain development and potential neurodevelopmental challenges.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11563839 | PMC |
http://dx.doi.org/10.1016/j.cmpb.2024.108479 | DOI Listing |
Introduction Respiratory distress syndrome (RDS) is a leading cause of morbidity and mortality among preterm infants, necessitating effective treatment strategies. This study compared the efficacy of Beractant (SURVANTA®) to Poractant alfa (CUROSURF®) in treating RDS in preterm infants admitted to Tawam Hospital in the UAE. Methodology This retrospective study included preterm infants from 23+0 to 36+6 weeks of gestation with a diagnosis of RDS and treatment by Beractant or Poractant alfa within 48 hours of life between January 2020 and March 2023.
View Article and Find Full Text PDFBMC Pediatr
December 2024
Developing Brain Institute, Children's National Hospital, 111 Michigan Avenue, NW, Washington, DC, USA.
Background: Intravenous lipid emulsions are an essential component of nutritional support for very preterm infants. Many neonatal intensive care units have transitioned from traditional soybean oil-only to fish oil-containing multicomponent lipid emulsions, but the neurodevelopmental implications have not been well-explored. The primary aim of this study was to assess extrauterine third trimester brain growth in very preterm infants supported with soybean oil-only compared to fish-oil containing multicomponent lipid emulsions; white matter development and neurobehavioral regulation at term were also investigated.
View Article and Find Full Text PDFFront Cell Infect Microbiol
December 2024
Data Center, Meizhou People's Hospital, Meizhou Academy of Medical Sciences, Meizhou, China.
Background: Premature infants are at high risk for neonatal respiratory distress syndrome (RDS) and secondary infections. This study aims to investigate the association between immunoinflammatory markers-the systemic immune inflammation index (SII), systemic inflammation response index (SIRI), and neutrophil-to-albumin ratio (NAR)-and the risk of developing RDS in premature infants.
Methods: A total of 2164 premature infants were enrolled in this retrospective study.
Cureus
November 2024
Pediatrics, K S Hegde Medical Academy, Mangaluru, IND.
Antenatal corticosteroids (ACS) are widely used to reduce respiratory distress syndrome (RDS) in preterm neonates, enhancing neonatal outcomes. However, the potential effects of ACS on other aspects of neonatal health, such as cortisol levels and glucose regulation, remain a concern. This study examines whether ACS administration impacts cortisol and glucose homeostasis in preterm infants by analyzing data from 14 selected studies.
View Article and Find Full Text PDFCureus
November 2024
Keep Well, Model of Care, Eastern Health Cluster, Dammam, SAU.
Preterm birth, defined as delivery before 37 weeks of gestation, is a significant contributor to neonatal morbidity and mortality worldwide. Understanding the prevalence of preterm birth is critical to improving neonatal care, informing public health strategies, and supporting health care planning. The objective of this study was to explore the problem of preterm birth in Saudi Arabia by estimating the prevalence of preterm birth over a defined period of time.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!